Sickle Cell Disease in Basra: Evidence-Based evaluation and insigh
Main Article Content
Abstract
Sickle cell disease (SCD) should be framed at the outset as the major hemoglobinopathy burden in Basra. A large epidemiological analysis from southern Iraq showed that SCD constituted 68.58% of registered hemoglobinopathy cases in Basrah, with a reported general prevalence of 238 per 100,000 population and a sickle cell trait frequency reaching 6.5%. The same study described Basrah as hosting the largest cohort of hemoglobinopathy patients in Iraq, underscoring the need to approach SCD as a sustained public health priority rather than a sporadic specialist problem
Article Details
How to Cite
ABDULHASAN, BASIM.
Sickle Cell Disease in Basra: Evidence-Based evaluation and insigh.
Medical Research Archives, [S.l.], v. 14, n. 4, may 2026.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/7479>. Date accessed: 01 may 2026.
Keywords
Sickle cell disease, Basra
Section
Editorial
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.